Chronic obstructive pulmonary disease (COPD) is a group of lung diseases that make it harder to breathe. The term "chronic" means the condition lasts a long time, and "obstructive" describes how the airways become narrowed or blocked. According to the Centers for Disease Control and Prevention, about 15 million American adults have been told they have COPD, though many more may have it without knowing.
Learn About Paying Your FGUA Bill Online →
To understand COPD, it helps to know how healthy lungs work. When you breathe in, air travels down your windpipe into smaller and smaller tubes called airways. These airways end in tiny air sacs called alveoli, where oxygen moves into your blood and carbon dioxide moves out. Your diaphragm, a muscle below your lungs, contracts to pull air in and relaxes to push air out.
In COPD, something damages the airways and air sacs, making them less elastic and more prone to collapse. This damage traps stale air in your lungs, making it harder to exhale and leaving less room for fresh oxygen-rich air. The walls of the airways also become thick and inflamed, narrowing the passage further. Imagine trying to breathe through a coffee stirrer that's partially blocked—that's closer to what people with COPD experience.
COPD actually includes two main conditions: emphysema and chronic bronchitis. In emphysema, the air sacs themselves are damaged and lose their shape. In chronic bronchitis, the tubes that carry air become inflamed and produce excess mucus, causing a persistent cough. Many people with COPD have both conditions at different levels of severity. The damage in COPD is usually progressive, meaning it typically gets worse over time without proper management.
Practical takeaway: Understanding that COPD involves both airway narrowing and air sac damage helps explain why shortness of breath and coughing are hallmark symptoms. This foundation makes it easier to understand why alpha-1 antitrypsin deficiency causes such significant lung problems—it removes one of your lungs' natural protective systems.
Alpha-1 antitrypsin (AAT) is a protein your liver produces that travels through your bloodstream to your lungs, where it protects lung tissue from damage. Think of it as a bodyguard that prevents immune cells and inflammatory substances from harming the delicate structures in your airways and air sacs. When your body doesn't make enough AAT—or makes a form that doesn't work properly—your lungs become vulnerable to damage that can lead to COPD.
Free Guide to Pay by Plate Illinois Billing →
Alpha-1 antitrypsin deficiency is an inherited condition caused by genetic mutations. You inherit genes from both parents. If you inherit two copies of the defective gene (one from each parent), you have severe AAT deficiency, sometimes called PiZZ genotype. If you inherit one defective copy and one normal copy, you have partial deficiency, which may or may not cause problems depending on other factors. The National Heart, Lung, and Blood Institute estimates that between 80,000 and 100,000 Americans have severe alpha-1 antitrypsin deficiency, though diagnosis rates are much lower—suggesting many people remain undiagnosed.
This genetic form of COPD differs importantly from the smoking-related form. While smoking damages lungs in anyone, people with AAT deficiency can develop severe emphysema even without smoking—sometimes starting in their 30s or 40s. A person with AAT deficiency who also smokes faces accelerated lung damage. Research shows that people with severe AAT deficiency who smoke tend to develop COPD about 15 years earlier than smokers without the deficiency.
The gene that makes alpha-1 antitrypsin sits on chromosome 14. Different mutations lead to different levels of protein production. The PiMM genotype is normal, producing adequate AAT. The PiMZ genotype produces borderline amounts. The PiZZ and other rare types produce very little functional protein. Blood tests can measure your AAT level and identify which genes you carry, helping determine your risk for lung disease.
Practical takeaway: If you or a family member developed COPD at an unusually young age, had COPD without significant smoking history, or have a family history of early emphysema, AAT deficiency testing may be worth discussing with a doctor. This genetic connection means screening can identify at-risk family members before lung damage occurs.
COPD symptoms often develop slowly, which is why many people don't realize they have the disease until significant damage has already occurred. The most common symptoms include shortness of breath, chronic cough, and increased mucus production. Many people mistake these early signs for a lingering cold or simply attribute them to getting older or being out of shape.
Free Guide to Mold Removal Methods for Walls →
Shortness of breath in COPD typically worsens with activity. Someone might notice they can't keep up during a walk, climb stairs as easily as before, or feel winded doing tasks they used to do without effort. As the disease progresses, breathing becomes difficult even during rest. A chronic cough that persists for weeks or months is another hallmark sign—it may be dry at first but often produces mucus or phlegm. Some people develop a cough that's worse in the morning when mucus has accumulated overnight in the airways.
Other symptoms include wheezing (a whistling sound when breathing), chest tightness, fatigue, frequent respiratory infections, and swollen ankles or legs (which can indicate the heart is working harder due to lung disease). Some people experience weight loss because they use extra energy to breathe. Cyanosis—a bluish tint to lips or fingernails—can indicate severely low oxygen levels and needs immediate medical attention.
Doctors typically test for COPD using spirometry, a simple breathing test. You breathe into a machine that measures how much air your lungs hold and how fast you can exhale. This test can detect airflow obstruction even before symptoms become severe. If spirometry shows reduced airflow, further testing like chest X-rays or CT scans may follow. For people with COPD diagnosed before age 45, or those without significant smoking exposure, testing for AAT deficiency should be part of the evaluation. A simple blood test measures your AAT level, and genetic testing can identify which mutations you carry if levels are low.
Practical takeaway: If you notice a persistent cough lasting more than three weeks, new or worsening shortness of breath with activity, or increased mucus production, scheduling a doctor's visit opens the door to potential early diagnosis. Early detection—especially for AAT-related COPD—can help slow disease progression through earlier intervention.
The relationship between alpha-1 antitrypsin deficiency and rapid COPD development comes down to cellular protection. Your lungs face constant challenges from inflammation and immune activity. Neutrophils, a type of white blood cell, release enzymes called neutrophil elastase when fighting infection or responding to irritants like cigarette smoke. These powerful enzymes break down damaged tissue to clear it away. AAT normally acts as a brake on this process, preventing the elastase from damaging healthy lung tissue.
How to Delete Your Fitbit Account Guide →
When AAT levels are inadequate, elastase operates with fewer restrictions. It begins breaking down the elastic fibers in your alveoli—the structures that allow your lungs to expand and contract like a balloon. Once these delicate air sacs are destroyed, they don't regenerate. This explains why people with AAT deficiency develop emphysema so aggressively. A person with severe deficiency can lose lung function that a smoker without deficiency might take 20 years to lose—sometimes in just 10 to 15 years if they also smoke.
The damage is particularly pronounced in the lower and middle portions of the lungs, which distinguishes AAT-related emphysema from smoking-related emphysema (which typically affects the upper lobes more). This pattern can actually be a clue on imaging studies that AAT deficiency may be present. Additionally, the liver itself can be affected—some people with AAT deficiency develop cirrhosis or liver cancer because the misshapen protein accumulates in liver cells instead of being secreted properly.
Smoking accelerates this damage exponentially.
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.